“We had been considering entering new markets such as Romania for some time. We are aware of the significant development of the Romanian health care sector, while we also consider reproductive medicine in the country on very high level. In this respect, Gynera represents ideal opportunity for such entrance as it has long history of success stories and leadership that pioneered IVF in the country,” said Matej Stejskal, CEO of FutureLife.
Located in Bucharest, Gynera belongs to 20 IVF providers in Romania, half of which are situated in Bucharest. It was founded and ran by Dr. Laura Dracea, who has been among the first practitioners that introduced assisted reproduction in Romania.
The transaction is still undergoing local regulatory requirements in order to be effective.
After the transaction Dr. Dracea will remain a shareholder at the company and will continue as the medical director and CEO of Gynera.
Founded in 2007 as the first clinic specialized and entirely dedicated to reproductive medicine, Gynera successfully treated over 20,000 infertile patients, but also conducted educational, academic, research and social programs. With a sustained yearly growth, over 800 IVF cycles per year and the largest number of IVF babies conceived over the last 10 years in Romania, Gynera consolidated its leading position between assisted reproduction providers in the country.
FutureLife is one of Europe’s top three largest and fastest growing providers of human assisted reproduction services with a presence in the Ireland, United Kingdom, Romania, Czech and Slovak Republics. The Group is also one of the largest fertility service providers worldwide, with over 25,000 IVF cycles performed annually. The majority owner of FutureLife is Hartenberg Holding a company focused on investments in assets primarily in Central Europe with equity commitments from the founders of EUR200 million.
“Geographical expansion has been one of our key initiatives for the shareholders’ value enhancement at FutureLife. Partnering with a leading clinic in Romania, with Gynera, we are setting up the cornerstone and platform for future acquisitions on the market. Our ultimate goal is to become market leader within next few years and to provide best in class fertility treatment with strong focus on the quality of the service provided for the patient,” said Jozef Janov, managing partner of Hartenberg Holding.